Over the past three decades, cancer research has evolved from random discovery to a targeted scientific endeavor, bringing revolutionary changes in our understanding and treatment of the disease. Significant advancements in cancer biology have led to new treatments, such as CAR T cell therapy. These therapies have not only revolutionized oncology but also show potential in treating other conditions. Penn Medicine, a major contributor to this progress, enhances hope for patients unresponsive to traditional therapies and leads the way in implementing these innovative treatments. The approval of 20 new cancer treatments and detection methods over the last five years signals marked progress. This advancement is due to an enhanced understanding of cancer biology, leading to novel therapies designed to manipulate the inherent vulnerabilities of cancer cells. Additionally, therapies like CAR T cell therapy show promise in treating autoimmune diseases, extending hope to millions worldwide.
Full article here: https://medium.com/@lawsuithelpdesk/dawn-of-a-new-era-unravelling-the-revolution-in-cancer-treatments-and-its-promise-beyond-oncology-52d2a7a05112